Evidence map›Paper›PMID 29915598›Full record

ReviewFrontiers in immunology2018

The Interaction of Human Pathogenic Fungi With C-Type Lectin Receptors.

Surabhi Goyal, Juan Camilo Castrillón-Betancur, Esther Klaile, Hortense Slevogt

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 129 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. β-1,3-Glucan recognition byApplied and environmental microbiology · 2024
    Article
  16. Dectin-1 as a therapeutic target for inflammatory bowel disease.Advances in pharmacology (San Diego, Calif.) · 2024
    Review
  17. Accelerating the understanding ofCurrent research in microbial sciences · 2024
    Review
  18. Article
  19. Review
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Surabhi GoyalInstitute for Microbiology and Hygiene, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Juan Camilo Castrillón-BetancurSeptomics Research Center, Jena University Hospital, Jena, Germany.
Esther KlaileSeptomics Research Center, Jena University Hospital, Jena, Germany.
Hortense SlevogtSeptomics Research Center, Jena University Hospital, Jena, Germany.
Jena University Hospital · DECharité - Universitätsmedizin Berlin · DELeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungi, usually present as commensals, are a major cause of opportunistic infections in immunocompromised patients. Such infections, if not diagnosed or treated properly, can prove fatal. However, in most cases healthy individuals are able to avert the fungal attacks by mounting proper antifungal immune responses. Among the pattern recognition receptors (PRRs), C-type lectin receptors (CLRs) are the major players in antifungal immunity. CLRs can recognize carbohydrate ligands, such as β-glucans and mannans, which are mainly found on fungal cell surfaces. They induce proinflammatory immune reactions, including phagocytosis, oxidative burst, cytokine, and chemokine production from innate effector cells, as well as activation of adaptive immunity

Indexed as

Host-Pathogen InteractionsAntifungal AgentsBiomarkersDrug Resistance, FungalFungiHumansLectins, C-TypeLigandsMycosesOpportunistic InfectionsSignal TransductionAntifungal AgentsBiomarkersLectins, C-TypeLigandsAspergillusCandidaC-type lectin receptorpathogenic fungipattern recognition receptorsingle nucleotide polymorphisms

Identifiers

PMID29915598
PMCPMC5994417
OpenAlexW2803328907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.